154 related articles for article (PubMed ID: 35812064)
21. Sanguinarine impedes metastasis and causes inversion of epithelial to mesenchymal transition in breast cancer.
Ghauri MA; Su Q; Ullah A; Wang J; Sarwar A; Wu Q; Zhang D; Zhang Y
Phytomedicine; 2021 Apr; 84():153500. PubMed ID: 33626427
[TBL] [Abstract][Full Text] [Related]
22. Regulation of cell growth and migration by miR-96 and miR-183 in a breast cancer model of epithelial-mesenchymal transition.
Anderson O; Guttilla Reed IK
PLoS One; 2020; 15(5):e0233187. PubMed ID: 32396572
[TBL] [Abstract][Full Text] [Related]
23. NR2F2 plays a major role in insulin-induced epithelial-mesenchymal transition in breast cancer cells.
Xia B; Hou L; Kang H; Chang W; Liu Y; Zhang Y; Ding Y
BMC Cancer; 2020 Jul; 20(1):626. PubMed ID: 32631390
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of CFTR promotes epithelial-to-mesenchymal transition and is associated with poor prognosis of breast cancer.
Zhang JT; Jiang XH; Xie C; Cheng H; Da Dong J; Wang Y; Fok KL; Zhang XH; Sun TT; Tsang LL; Chen H; Sun XJ; Chung YW; Cai ZM; Jiang WG; Chan HC
Biochim Biophys Acta; 2013 Dec; 1833(12):2961-2969. PubMed ID: 23916755
[TBL] [Abstract][Full Text] [Related]
25. TAZ promotes vasculogenic mimicry in gastric cancer through the upregulation of TEAD4.
Zhang Y; Bai J; Cheng R; Zhang D; Qiu Z; Liu T; Che N; Dong X; Zhao N; Lin X; Liang X; Li F; Li Y; Sun B; Zhao X
J Gastroenterol Hepatol; 2022 Apr; 37(4):714-726. PubMed ID: 35062042
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
28. Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression.
Xie D; Cui J; Xia T; Jia Z; Wang L; Wei W; Zhu A; Gao Y; Xie K; Quan M
Oncotarget; 2015 Nov; 6(34):35949-63. PubMed ID: 26416426
[TBL] [Abstract][Full Text] [Related]
29. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145.
Ren D; Wang M; Guo W; Zhao X; Tu X; Huang S; Zou X; Peng X
Int J Oncol; 2013 Apr; 42(4):1473-81. PubMed ID: 23404342
[TBL] [Abstract][Full Text] [Related]
30. Pomegranate peel extract inhibits expression of β-catenin, epithelial mesenchymal transition, and metastasis in triple negative breast cancer cells.
Bagheri M; Fazli M; Saeednia S; Kor A; Ahmadiankia N
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(7):86-91. PubMed ID: 29974851
[TBL] [Abstract][Full Text] [Related]
31. VASN promotes YAP/TAZ and EMT pathway in thyroid carcinogenesis in vitro.
Bhandari A; Guan Y; Xia E; Huang Q; Chen Y
Am J Transl Res; 2019; 11(6):3589-3599. PubMed ID: 31312369
[TBL] [Abstract][Full Text] [Related]
32. miR-143 suppresses epithelial-mesenchymal transition and inhibits tumor growth of breast cancer through down-regulation of ERK5.
Zhai L; Ma C; Li W; Yang S; Liu Z
Mol Carcinog; 2016 Dec; 55(12):1990-2000. PubMed ID: 26618772
[TBL] [Abstract][Full Text] [Related]
33. MHP-1 inhibits cancer metastasis and restores topotecan sensitivity via regulating epithelial-mesenchymal transition and TGF-β signaling in human breast cancer cells.
Lin S; Lyu X; Yu J; Sun L; Du D; Lai Y; Li H; Wang Y; Zhang L; Yin H; Yuan S
Phytomedicine; 2016 Sep; 23(10):1053-63. PubMed ID: 27444351
[TBL] [Abstract][Full Text] [Related]
34. FOXO3a inhibits the EMT and metastasis of breast cancer by regulating TWIST-1 mediated miR-10b/CADM2 axis.
Jin L; Zhang J; Fu HQ; Zhang X; Pan YL
Transl Oncol; 2021 Jul; 14(7):101096. PubMed ID: 33882368
[TBL] [Abstract][Full Text] [Related]
35. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
36. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
[TBL] [Abstract][Full Text] [Related]
37. Taxifolin inhibits breast cancer cells proliferation, migration and invasion by promoting mesenchymal to epithelial transition via β-catenin signaling.
Li J; Hu L; Zhou T; Gong X; Jiang R; Li H; Kuang G; Wan J; Li H
Life Sci; 2019 Sep; 232():116617. PubMed ID: 31260685
[TBL] [Abstract][Full Text] [Related]
38. Adenovirus-mediated TIPE2 overexpression inhibits gastric cancer metastasis via reversal of epithelial-mesenchymal transition.
Yin H; Huang X; Tao M; Hu Q; Qiu J; Chen W; Wu J; Xie Y
Cancer Gene Ther; 2017 Apr; 24(4):180-188. PubMed ID: 28186089
[TBL] [Abstract][Full Text] [Related]
39. TAZ promotes epithelial to mesenchymal transition via the upregulation of connective tissue growth factor expression in neuroblastoma cells.
Wang Q; Xu Z; An Q; Jiang D; Wang L; Liang B; Li Z
Mol Med Rep; 2015 Feb; 11(2):982-8. PubMed ID: 25354978
[TBL] [Abstract][Full Text] [Related]
40. Propolin G-Suppressed Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer Cells via Glycogen Synthase Kinase 3β-Mediated Snail and HDAC6-Regulated Vimentin Degradation.
Pai JT; Chen XH; Leu YL; Weng MS
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]